Fludeoxyglucose F-18 Injection
Product Images NDC 78714-001

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fludeoxyglucose F-18 (NDC 78714-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Barbara Ann Karmanos Cancer Hospital, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Fludeoxyglucose 01)

Chemical structure of Fludeoxyglucose F-18 showing the molecular arrangement including a fluorine-18 isotope incorporated in the glucose molecule, consistent with the labeled radiopharmaceutical compound used in PET imaging.*

FDA Label Image

Principal Display Panel (30 mL Glass Vial Label)

Label for Fludeoxyglucose F 18 Injection, 20-300 mCi/mL strength, a sterile intravenous injection indicated for diagnostic use. The label includes storage instructions, radioactive material caution, half-life information (109.8 minutes), and manufacturer details for Karmanos Cancer Institute, Detroit, Michigan. The label notes this is a multiple-dose vial with expiration 12 hours after End of Synthesis (EOS).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.